Share-based Payment Arrangement, Expense of Eledon Pharmaceuticals, Inc. from 31 Dec 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Eledon Pharmaceuticals, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2012 to 30 Sep 2025.
  • Eledon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,428,000, a 36% increase year-over-year.
  • Eledon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $14,568,000, a 77% increase year-over-year.
  • Eledon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $13,122,000, a 100% increase from 2023.
  • Eledon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6,545,000, a 20% decline from 2022.
  • Eledon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8,153,000, a 3.2% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Eledon Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $14,568,000 $2,428,000 +$645,000 +36% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $13,923,000 $2,694,000 -$369,000 -12% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $14,292,000 $2,864,000 +$1,170,000 +69% 01 Jan 2025 31 Mar 2025 10-Q/A 14 Aug 2025 2025 Q1
Q4 2024 $13,122,000 $6,582,000 +$4,872,000 +285% 01 Oct 2024 31 Dec 2024 10-K/A 14 Aug 2025 2024 FY
Q3 2024 $8,250,000 $1,783,000 +$49,000 +2.8% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $8,201,000 $3,063,000 +$1,343,000 +78% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $6,858,000 $1,694,000 +$313,000 +23% 01 Jan 2024 31 Mar 2024 10-Q/A 14 Aug 2025 2025 Q1
Q4 2023 $6,545,000 $1,710,000 +$236,000 +16% 01 Oct 2023 31 Dec 2023 10-K/A 14 Aug 2025 2024 FY
Q3 2023 $6,309,000 $1,734,000 -$451,000 -21% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $6,760,000 $1,720,000 -$588,000 -25% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024 2024 Q2
Q1 2023 $7,348,000 $1,381,000 -$805,000 -37% 01 Jan 2023 31 Mar 2023 10-Q/A 19 Aug 2024 2024 Q1
Q4 2022 $8,153,000 $1,474,000 -$579,000 -28% 01 Oct 2022 31 Dec 2022 10-K/A 19 Aug 2024 2023 FY
Q3 2022 $8,732,000 $2,185,000 +$142,000 +7% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $8,590,000 $2,308,000 +$274,000 +13% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $8,316,000 $2,186,000 +$412,000 +23% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $7,904,000 $2,053,000 +$394,000 +24% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $7,510,000 $2,043,000 +$1,165,000 +133% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $6,345,000 $2,034,000 +$1,837,000 +932% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $4,508,000 $1,774,000 +$1,337,000 +306% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $3,171,000 $1,659,000 +$1,416,000 +583% 01 Oct 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 $1,755,000 $878,000 +$651,000 +287% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $1,104,000 $197,000 -$430,000 -69% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $1,534,000 $437,000 +$226,000 +107% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q4 2019 $1,308,000 $243,000 -$498,000 -67% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $1,806,000 $227,000 -$10,000 -4.2% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2020 Q3
Q2 2019 $1,816,000 $627,000 +$223,000 +55% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2020 Q2
Q1 2019 $1,593,000 $211,000 +$50,000 +31% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q4 2018 $1,543,000 $741,000 01 Oct 2018 31 Dec 2018 10-K 17 Mar 2020 2019 FY
Q3 2018 $237,000 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2019 Q3
Q2 2018 $404,000 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019 2019 Q2
Q1 2018 $161,000 +$55,000 +52% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q1 2017 $745,000 $106,000 -$916,000 -90% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018 2018 Q1
Q4 2016 $171,000 $2,489,000 -$3,346,000 -390% 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 $3,517,000 $646,000 -$158,000 -20% 01 Jul 2016 30 Sep 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 $3,675,000 $992,000 +$386,000 +64% 01 Apr 2016 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 $3,289,000 $1,022,000 +$388,000 +61% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017 2017 Q1
Q4 2015 $2,901,000 $857,000 +$268,000 +46% 01 Oct 2015 31 Dec 2015 10-K 03 Mar 2017 2016 FY
Q3 2015 $2,633,000 $804,000 -$375,000 -32% 01 Jul 2015 30 Sep 2015 10-Q 03 Nov 2016 2016 Q3
Q2 2015 $3,008,000 $606,000 +$356,000 +142% 01 Apr 2015 30 Jun 2015 10-Q 04 Aug 2016 2016 Q2
Q1 2015 $2,652,000 $634,000 +$544,000 +604% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q4 2014 $2,108,000 $589,000 01 Oct 2014 31 Dec 2014 10-K 03 Mar 2017 2016 FY
Q3 2014 $1,179,000 +$1,132,000 +2409% 01 Jul 2014 30 Sep 2014 10-Q 10 Nov 2015 2015 Q3
Q2 2014 $250,000 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015 2015 Q2
Q1 2014 $90,000 01 Jan 2014 31 Mar 2014 10-Q 12 May 2015 2015 Q1
Q3 2013 $47,000 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014 2014 Q3

Eledon Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $13,122,000 +$6,577,000 +100% 01 Jan 2024 31 Dec 2024 10-K/A 14 Aug 2025 2024 FY
2023 $6,545,000 -$1,608,000 -20% 01 Jan 2023 31 Dec 2023 10-K/A 14 Aug 2025 2024 FY
2022 $8,153,000 +$249,000 +3.2% 01 Jan 2022 31 Dec 2022 10-K/A 19 Aug 2024 2023 FY
2021 $7,904,000 +$4,733,000 +149% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $3,171,000 +$1,863,000 +142% 01 Jan 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
2019 $1,308,000 -$235,000 -15% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $1,543,000 +$964,000 +166% 01 Jan 2018 31 Dec 2018 10-K 17 Mar 2020 2019 FY
2017 $579,000 +$408,000 +239% 01 Jan 2017 31 Dec 2017 10-K 28 Mar 2019 2018 FY
2016 $171,000 -$2,730,000 -94% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 $2,901,000 +$793,000 +38% 01 Jan 2015 31 Dec 2015 10-K 03 Mar 2017 2016 FY
2014 $2,108,000 +$1,870,000 +786% 01 Jan 2014 31 Dec 2014 10-K 03 Mar 2017 2016 FY
2013 $238,000 +$28,000 +13% 01 Jan 2013 31 Dec 2013 10-K 10 Mar 2016 2015 FY
2012 $210,000 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.